Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
Media Food Facts: How true are they?
February 15, 2019
Travelling in a Wheelchair: A patient’s story
February 15, 2019
We Only Sing When We’re Wheezing!
February 15, 2019
Doctors need empathy
February 15, 2019
New Christmas Quiz Champion Crowned
February 15, 2019
National and European Centre of Excellence in Medical Mycology
February 15, 2019
COPD – getting the best out of treatments
February 15, 2019
EU debate on biosimilar drugs
February 15, 2019
Number of People in UK With Fungal Disease Rises
February 15, 2019
Medicine for the Mind
February 15, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video